# Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions

> **NCT01717235** · PHASE1 · COMPLETED · sponsor: **Lupin Ltd.** · enrollment: 12 (actual)

## Conditions studied

- Pharmacokinetic Study

## Interventions

- **DRUG:** Ropinirole hydrochloride CR Tablets 2mg

## Key facts

- **NCT ID:** NCT01717235
- **Lead sponsor:** Lupin Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2008-10
- **Final completion:** 2008-11
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01717235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01717235, "Bioequivalence Study of Ropinirole Hydrochloride CR 2mg Tablets of Lupin Limited, India, With REQUIP XL of GlaxoSmithKline Research Triangle Park, in Healthy, Adult, Male, Subjects Under Fasting Conditions". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01717235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*